Regarding immunomodulatory properties, it was also reported that COPD patients with A1ATD had higher TNF-α, IL-6, IL-1β, and IL-8 production in comparison to COPD patients without A1ATD [12, 13, 30]. The gene discussed is IL6; the disease is chronic obstructive pulmonary disease.